THYROGLOSSAL CYST

THYROGLOSSAL CYST was reported 51 times

THYROGLOSSAL CYST is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Potassium-sparing Diuretic [EPC] 2 0.0001
1 Non-Standardized Plant Allergenic Extract [EPC] 1 0.0001
2 Protease Inhibitor [EPC] 2 0.0000
3 Antimycobacterial [EPC] 1 0.0000
4 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0000
5 Androgen [EPC] 1 0.0000
6 Provitamin D2 Compound [EPC] 1 0.0000
7 Cytochrome P450 3A Inhibitor [EPC] 2 0.0000
8 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3 0.0000
9 Interleukin-17A Antagonist [EPC] 1 0.0000
10 Integrin Receptor Antagonist [EPC] 2 0.0000
11 Insulin [EPC] 1 0.0000
12 HMG-CoA Reductase Inhibitor [EPC] 5 0.0000
13 Non-Standardized Food Allergenic Extract [EPC] 1 0.0000
14 Angiotensin 2 Receptor Blocker [EPC] 4 0.0000
15 Catecholamine [EPC] 1 0.0000
16 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
17 Prostaglandin Analog [EPC] 1 0.0000
18 Estrogen [EPC] 2 0.0000
19 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
20 Acetylcholine Release Inhibitor [EPC] 1 0.0000
21 Thiazide Diuretic [EPC] 2 0.0000
22 Interleukin-23 Antagonist [EPC] 1 0.0000
23 Antirheumatic Agent [EPC] 1 0.0000
24 GLP-1 Receptor Agonist [EPC] 4 0.0000
25 Sulfonylurea [EPC] 1 0.0000
26 Azole Antifungal [EPC] 1 0.0000
27 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
28 Interferon beta [EPC] 1 0.0000
29 Proton Pump Inhibitor [EPC] 3 0.0000
30 Folate Analog Metabolic Inhibitor [EPC] 2 0.0000
31 Kinase Inhibitor [EPC] 2 0.0000
32 Progestin [EPC] 1 0.0000
33 CD20-directed Cytolytic Antibody [EPC] 1 0.0000
34 Corticosteroid [EPC] 4 0.0000
35 Benzodiazepine [EPC] 2 0.0000
36 Insulin Analog [EPC] 1 0.0000
37 Atypical Antipsychotic [EPC] 1 0.0000
38 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
39 Thalidomide Analog [EPC] 1 0.0000
40 Platelet Aggregation Inhibitor [EPC] 1 0.0000
41 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000